Detalhe da pesquisa
1.
A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics.
Analyst
; 147(19): 4275-4284, 2022 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997223
2.
A Novel Class of On-Treatment Cancer Immunotherapy Biomarker: Trough Levels of Antibody Therapeutics in Peripheral Blood.
Immunol Invest
; 51(8): 2159-2175, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36301695
3.
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma.
Am J Hematol
; 95(5): 510-520, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32052473
4.
Implementation and Validation of an Automated Flow Cytometry Analysis Pipeline for Human Immune Profiling.
Cytometry A
; 95(2): 183-191, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30570217
5.
CD28-CD80 interactions control regulatory T cell motility and immunological synapse formation.
J Immunol
; 193(12): 5894-903, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25355918
6.
A cell-intrinsic requirement for NF-κB-inducing kinase in CD4 and CD8 T cell memory.
J Immunol
; 191(7): 3663-72, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24006459
7.
Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites.
J Immunother Cancer
; 12(1)2024 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212122
8.
Cyclosporine-resistant, Rab27a-independent mobilization of intracellular preformed CD40 ligand mediates antigen-specific T cell help in vitro.
J Immunol
; 187(2): 626-34, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21677130
9.
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 9(1): 53, 2023 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344474
10.
Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086949
11.
Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34620702
12.
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells.
Nat Commun
; 12(1): 1047, 2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33594075
13.
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.
J Immunother Cancer
; 9(4)2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837055
14.
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone.
J Immunother Cancer
; 8(2)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616555
15.
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.
J Immunother Cancer
; 8(2)2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33268350
16.
Toll-like receptor 2 (TLR2) and dectin-1 contribute to the production of IL-12p40 by bone marrow-derived dendritic cells infected with Penicillium marneffei.
Microbes Infect
; 10(10-11): 1223-7, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18652908
17.
Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.
Front Immunol
; 13: 939789, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35720421
18.
Limited contribution of Toll-like receptor 2 and 4 to the host response to a fungal infectious pathogen, Cryptococcus neoformans.
FEMS Immunol Med Microbiol
; 47(1): 148-54, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16706798
19.
A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood.
J Vis Exp
; (108): e53485, 2016 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26890325
20.
Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab.
Cancer Res
; 75(23): 5084-92, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26627641